Stephen Taub Lone Pine Falls on Some Icarus Bets Stephen Mandel Jr.’s firm blames first-quarter underperformance on “incorrect assessment of risk” on a pipeline merger and Valeant Pharmaceuticals. Stephen Taub April 18, 2016